Tools for Practice Outils pour la pratique


#74 Coffee: Advice for our Vice?


CLINICAL QUESTION
QUESTION CLINIQUE
Does drinking coffee impact mortality or other health outcomes in the general population?


BOTTOM LINE
RÉSULTAT FINAL
Coffee consumption is associated with a possible small reduction in mortality in cohort studies. While the evidence is not strong enough to recommend non-drinkers to start consuming coffee, coffee drinkers can be reassured that it does not result in harm (except in pregnancy).



CFPCLearn Logo

Reading Tools for Practice Article can earn you MainPro+ Credits

La lecture d'articles d'outils de pratique peut vous permettre de gagner des crédits MainPro+

Join Now S’inscrire maintenant

Already a CFPCLearn Member? Log in

Déjà abonné à CMFCApprendre? Ouvrir une session



EVIDENCE
DONNÉES PROBANTES
Meta-analysis1 of 21 cohort studies including 997,464 people in US, Europe or Japan 
  • Largest included cohort study2 followed 402,260 people in US (age 50-71 years) for 14 years 
    • Drinking coffee was associated with several confounders (more likely to smoke cigarettes, drink alcohol, be physically inactive, and have poor diet) 
  • After adjusting for confounders, coffee drinkers (compared to those that did not drink coffee), had a statistically significant lower risk of overall mortality: 
    • About 15% relative risk reduction for 2-3 cups/day 
    • No dose-response relationship; risk was similar whether individuals drank 1 or 8 cups/day 
  • Cardiovascular deaths decreased, deaths due to cancer were unchanged. 
Other meta-analyses3,4 (including one of 36 observational studies of 1,279,804 individuals3) found similar results for cardiovascular events and mortality. Context:  
  • Decaffeinated coffee seems to convey similar health benefits, so the benefit may not be due to caffeine.2 
  • Similar evidence for drinking tea.5 
  • Evidence is from cohort studies, and therefore can only show association (not causation) with reduced mortality 
    • Unfortunately, a large randomized controlled trial is unlikely 
    • However, this evidence seems to rule out clinically important harm. 
  • Cancer rates: Some research suggests coffee consumption is associated with reduced rates of some cancers,6,7 while other studies find no association.7-10 
  • Coffee intake is also associated with a reduced risk of diabetes11 and depression.12 
  • Coffee use in pregnancy (particularly >4 cups/day) increases the risk of fetal loss.13 Pregnant women should be advised of this potential risk. 


Latest Tools for Practice
Derniers outils pour la pratique

#364 Facing the Evidence in Acne, Part II: Oral Antibiotics

How effective are oral antibiotics in treating acne of at least mild-moderate severity?
Read Lire 0.25 credits available Crédits disponibles

#363 Making a difference in indifference? Medications for apathy in dementia

In patients with dementia, how safe and effective are stimulants, antidepressants, and antipsychotics for treating apathy?
Read Lire 0.25 credits available Crédits disponibles

#362 Facing the Evidence in Acne, Part I: Oral contraceptives and spironolactone in females

How effective are combined oral contraceptives (COC) and spironolactone for treating acne of at least mild-moderate severity in females?
Read Lire 0.25 credits available Crédits disponibles

This content is certified for MainPro+ Credits, log in to access

Ce contenu est certifié pour les crédits MainPro+, Ouvrir une session


Author(s)
Auteur(s)
  • G. Michael Allan MD CCFP
  • Marco Mannarino MD CCFP

1. Crippa A, Discacciati A, Larsson SC, Wolk A, Orsini N. Am J Epidemiol 2014;180:763-75.

2. Freedman ND, Park Y, Abnet CC, et al. N Engl J Med 2012;366:1891-904.

3. Ding M, Bhupathiraju SN, Satija A, van Dam RM, Hu FB. Circulation 2014;129:643-59.

4. Zhao Y, Wu K, Zheng J, Zuo R, Li D. Public Health Nutrition 2014;18:1282-91.

5. Zhang C, Qin Y-Y, Wei X, Yu F-F, Zhou Y-H, He J. Eur J Epidemiol 2015;30:103-13.

6. Yu X, Bao Z, Zou J, et al. BMC Cancer 2011;11:96.

7. Turati F, Galeone C, La Vecchia C, et al. Ann Oncol 2011;22:536-44.

8. Park C-H, Myung S-K, Kim T-Y, et al. BJU Int 2010;106:762-9.

9. Turati F, Galeone C, Edefonti V, et al. Ann Oncol 2012;23:311-8.

10. Zhang X, Albanes D, Beeson WL, et al. J Natl Cancer Inst 2010;102:771–83.

11. Huxley R, Lee CMY, Barzi F, et al. Arch Intern Med 2009;169:2053-63.

12. Grosso G, Micek A, Castellano S, Pajak A, Galvano F. Mol Nutr Res 2016;60:223-34.

13. Li J, Zhao H, Song JM, Zhang J, Tang YL, Xin CM. Int J Gynaecol Obstet 2015;130:116-22.

Authors do not have any conflicts of interest to declare.

Les auteurs n’ont aucun conflit d’intérêts à déclarer.